EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Acupuncture Treatment for Breast Cancer-Related Lymphedema: A Randomized Pilot Study

Rosie Friedman, Anna Rose Johnson, Kathy Shillue, Aaron Fleishman, Chris Mistretta, Leo Magrini, Bao Ngoc N Tran, Stanley G Rockson, Weidong Lu, Gloria Y Yeh, Dhruv Singhal

Lymphatic Research and Biology · 01.10.2023 · 21 (5) · 488-494

DOI: 10.1089/lrb.2022.0001 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lymphatic Research and Biology, online erschienen am 17.10.2023. Verfasst von Rosie Friedman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachu…. Hauptthemen laut MEDLINE: Acupuncture Therapy, Breast Cancer Lymphedema, Quality of Life. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methods of conservative management for breast cancer-related lymphedema (BCRL) are burdensome in terms of time, cost, and convenience. In addition, many patients are not candidates for surgical treatment. Preliminary results have demonstrated possible beneficial effects of acupuncture for patients with BCRL. In this small pilot study, we examined the safety and feasibility of an acupuncture randomized control trial (RCT) in this patient cohort, utilizing a battery of standardized clinical and patient-centered outcome measures. Methods and Results: Patients with BCRL were randomized 2:1 to the acupuncture ( n = 10) or the control ( n = 4) group. Patients received acupuncture to the unaffected extremity biweekly for 6 weeks. Feasibility was defined as enrollment ≥80%, completion of ≥9 of 12 acupuncture sessions per person, and ≥75% completion of three of three measurement visits. To inform a future adequately powered RCT, we describe within-group changes in patient-centered outcomes, including circumferential measurements, bioimpedance spectroscopy, perometry, cytokine levels, and patient quality of life. Adverse events were systematically tracked. Fourteen patients completed the study. Of those who received acupuncture ( n = 10), 8 completed all 12 acupuncture sessions, and 2 patients completed 11 sessions. Ninety-three percent of all participants completed all three measurement visits. There was no consistent improvement in arm volumes. Inflammatory marker levels had inconclusive fluctuations among both groups. All patients receiving acupuncture demonstrated an improvement in their functional quality-of-life score. No severe adverse events occurred.

Conclusions

A randomized controlled study of acupuncture for BCRL is feasible. The acupuncture intervention is acceptable in this population, without safety concerns in a small sample and warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acupuncture TherapyBreast Cancer LymphedemaQuality of LifeHumansFemalePilot ProjectsMiddle AgedTreatment OutcomeAgedBreast NeoplasmsAdultCytokines

Stichwörter der Autor:innen

acupuncturebreast cancer-related lymphedemalymphedema

Substanzen

Cytokines

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Friedman, R., Johnson, A. R., Shillue, K., Fleishman, A., Mistretta, C., Magrini, L., Tran, B. N. N., Rockson, S. G., Lu, W., Yeh, G. Y., & Singhal, D. (2023). Acupuncture Treatment for Breast Cancer-Related Lymphedema: A Randomized Pilot Study. Lymphatic Research and Biology, 21(5), 488-494. https://doi.org/10.1089/lrb.2022.0001

Vancouver

Friedman R, Johnson AR, Shillue K, Fleishman A, Mistretta C, Magrini L, et al. Acupuncture Treatment for Breast Cancer-Related Lymphedema: A Randomized Pilot Study. Lymphatic Research and Biology. 2023;21(5):488-494. doi:10.1089/lrb.2022.0001

BibTeX
@article{Friedman2023,
  author = {Friedman, Rosie and Johnson, Anna Rose and Shillue, Kathy and Fleishman, Aaron and Mistretta, Chris and Magrini, Leo and Tran, Bao Ngoc N and Rockson, Stanley G and Lu, Weidong and Yeh, Gloria Y and Singhal, Dhruv},
  title = {Acupuncture Treatment for Breast Cancer-Related Lymphedema: A Randomized Pilot Study},
  journal = {Lymphatic Research and Biology},
  year = {2023},
  volume = {21},
  number = {5},
  pages = {488--494},
  doi = {10.1089/lrb.2022.0001}
}
Kostenlos starten →